Venture Capital News

Friday, February 3, 2012

PerkinElmer picks Atlas Venture's Barrett for board seat
PerkinElmer Inc. announced it will be filling an upcoming board vacancy with Peter Barrett, a partner at venture capital firm Atlas Venture.
Report: Cleantech VC dollars down in 2011 nationally
Venture dollars invested in the cleantech industry in 2011 were a mixed bag nationally, depending on comparison data, but it was enough to keep Massachusetts ranked second in the nation for cleantech investments, according to an Ernst & Young LLP analysis.

Monday, January 30, 2012

Seed-stage investor Experiment Fund launches in Cambridge
Student entrepreneurs in Cambridge may have reason to stick around the area with the launching of The Experiment Fund, a new seed stage investment fund focused on student startups and new technologies and platforms in Cambridge.

Thursday, January 26, 2012

MassBio: Mass. biotechs raised most venture capital in 2011
Massachusetts had its best year to date for venture capital in 2011, beating the 2010 historic high, the head of the Massachusetts Biotechnology Council told attendees at its policy leadership breakfast in Boston Wednesday.
Stretchable electronics firm MC10 boosted by $2M funding
Cambridge startup MC10 Inc., a maker of flexible electronics, raised $2 million in a funding round from Aberdare Ventures of San Francisco. As part of the investment, Aberdare managing partner Paul Klingenstein will join the MC10 board of directors.

Wednesday, January 25, 2012

XLerant adds $3M VC Series B round to budget
Connecticut software company XLerant Inc. has closed a $3 million Series B funding round led by Chrysalis Ventures, the company said Wednesday. The company plans to use the funds to grow sales and marketing efforts in North America.
Mevion Medical finds $45M in VC funding
Littleton’s Mevion Medical Systems said Wednesday it closed a $45 million investment to help the company commercialize its proton beam radiation therapy systems.

Friday, January 20, 2012

Study: Venture investment rose 22% in 2011
Venture capitalists opened their wallets wider in 2011, investing $28.4 billion, up 22 percent, in 3,673 deals, up 4 percent, according to a MoneyTree Report today.

Wednesday, January 18, 2012

RaNA Therapeutics emerges from stealth with $20.7M Series A round
RaNA Therapeutics Inc., a secretive company that is developing technology licensed from Mass. General Hospital, said it has completed a $20.7 million Series A round co-led by Atlas Venture, SR One, and Monsanto Co., with participation from Partners Innovation Fund.

Wednesday, January 11, 2012

Flagship Ventures $270M fourth VC fund, biggest yet
Cambridge's Flagship Ventures said Wednesday it's closed its fourth venture capital fund — its largest to date — at $270 million.

Friday, January 6, 2012

Social commerce firm Moontoast raises $6M
Moontoast LLC, a brand-focused social commerce software startup in Andover, has pulled together $6 million in a funding round led by Nashville venture capital firm The Martin Companies.

Thursday, January 5, 2012

Battery Ventures names two new general partners
Battery Ventures' Waltham office has named a new general partner, Jesse Feldman, who specializes in software and industrial technology investments. The firm also named another new general partner in Brian O'Malley, based in the Menlo Park, Calif., office.
GrabCAD sketches out a $4M bump in funding
Open source CAD software startup GrabCAD Inc. has taken in $4.2 million in new funding, boosting its initial tranche of $1.1 million in June according to an SEC filing this morning and the GrabCAD website.

Friday, December 30, 2011

FluoroPharma taps Ascent’s Atinsky for board seat
Boston’s FluoroPharma Medical Inc. has named Ascent Biomedical Ventures partner Lawrence Atinsky to the company’s board of directors, a position he will assume starting Jan. 3rd, 2012.

Friday, December 23, 2011

Acceleron raises $30M funding
Acceleron Pharma Inc.'s development and commercialization collaboration with New Jersey partner Celgene Corp. continues to pay off in the form of funding for the Cambridge biomedical company.

Wednesday, December 21, 2011

GMZ Energy's $14M funding a bright spot in energy VC investing
Despite the issues other energy startups are facing around raising money, GMZ Energy said its tech is getting plenty of interest, saying that its $14 million round was oversubscribed.

Tuesday, December 20, 2011

Therapeutics investor Access BridgeGap Ventures launches
A new life sciences-focused venture capital group has popped up in Cambridge. Access BridgeGap Ventures is the new early stage funding arm of New York industrial group Access Industries.

Thursday, December 15, 2011

Cerulean Pharma seals up $15M Series D backing
Ceruluean Pharma Inc. has rounded up a $15 million Series D funding, backed by new investor CVF LLC, to support its tumor-targeted nanopharmaceutical development.
Atlas Venture, Shire HGT team on new investments
Life sciences-focused venture capital firm Atlas Venture and Cambridge's Shire Human Genetic Therapies are partnering in an effort to find new investment areas in early stage rare disease therapeutics.
Ember Therapeutics launches with $34M of Third Rock's cash
Boston venture capital firm Third Rock Ventures LLC has officially launched a new biotech focused on metabolic disorders and obesity, feeding it $34 million in a Series A round and renaming it Ember Therapeutics.